#United States #New York #Class Action #Faruqi & Faruqi #Viatris

Ongoing Investigation by Faruqi & Faruqi, LLP on Behalf of Viatris Investors

Faruqi & Faruqi, LLP, a well-known national securities law firm, has announced an ongoing investigation targeting Viatris, Inc. (NASDAQ: VTRS) amid concerns surrounding the company's recent financial disclosures. With a prominent focus on investor protection, the law firm is particularly concerned about claims from those who have suffered significant financial losses, specifically exceeding $100,000, between August 8, 2024, and February 26, 2025.

The firm is encouraging affected investors to reach out to discuss their legal options and the possibility of joining a federal securities class action lawsuit against Viatris. The deadline for filing to become the lead plaintiff in this case is set for June 3, 2025. This lead plaintiff will lead the class action on behalf of all investors affected, aiming to recover damages resulting from alleged violations of federal securities laws.

Allegations Against Viatris

The investigation stems from allegations that Viatris and its executives have potentially misled investors regarding the company's financial outlook. Specifically, claims suggest that they failed to disclose vital information related to the company's projected revenue and growth due to issues concerning its Indore facility. Moreover, there are serious questions about the impact of a failed inspection by the U.S. Food and Drug Administration (FDA) that could affect Viatris’s supply chain and product shipment capabilities.

On February 27, 2025, Viatris released their earnings for the fourth quarter and the entire fiscal year of 2024, which included a lackluster forecast for fiscal 2025. This disappointing guidance was linked directly to the adverse financial implications stemming from the FDA’s warning letter concerning the Indore facility. Following this disclosure, Viatris’s stock price plummeted significantly from $11.24 per share to $9.53 in just one day, marking a drastic 15.21% decline, which raised alarms among investors.

Faruqi & Faruqi has a reputation for championing investor rights, with an impressive history of recovering hundreds of millions for clients since its inception in 1995. The firm is dedicated to ensuring that shareholders receive fair treatment, especially when misrepresentation or negligence potentially leads to significant financial harm.

What Investors Should Do

For any investors who feel they may have been misled or unduly influenced by the company's handling of its information, Faruqi & Faruqi LLP encourages direct communication. Interested parties are advised to contact attorney Josh Wilson via phone at 877-247-4292 or 212-983-9330 (Ext. 1310) for a consultation regarding their situation and potential involvement in the class action. Moreover, information for whistleblowers, former employees, or other witnesses to the company's conduct is also being solicited.

As legal matters develop, it remains crucial for investors to stay informed of updates regarding the Viatris class action and the investigation. Interested individuals can follow the ongoing developments on platforms like LinkedIn, X (Twitter), or Facebook, keeping abreast of new insights as they arise.

In conclusion, the investigation by Faruqi & Faruqi, LLP serves as a vital reminder for investors to remain vigilant and proactive, especially when facing financial losses potentially stemming from corporate misrepresentations. Immediate action may pave the way for possible recovery as the legal proceedings gain momentum.